Switch theme
Sign up to access all valuation multiples
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
1993
794
LTM Revenue $369M
LTM EBITDA $42.4M
$281M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Laboratorio Reig Jofre has a last 12-month revenue of $369M and a last 12-month EBITDA of $42.4M.
In the most recent fiscal year, Laboratorio Reig Jofre achieved revenue of $364M and an EBITDA of $38.9M.
Laboratorio Reig Jofre expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Laboratorio Reig Jofre valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $340M | $364M | XXX | XXX | XXX |
| Gross Profit | $169M | $192M | XXX | XXX | XXX |
| Gross Margin | 50% | 53% | XXX | XXX | XXX |
| EBITDA | $36.9M | $38.9M | XXX | XXX | XXX |
| EBITDA Margin | 11% | 11% | XXX | XXX | XXX |
| Net Profit | $8.7M | $10.1M | XXX | XXX | XXX |
| Net Margin | 3% | 3% | XXX | XXX | XXX |
| Net Debt | $40.3M | $35.7M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Laboratorio Reig Jofre's stock price is EUR 3 (or $3).
Laboratorio Reig Jofre has current market cap of EUR 219M (or $236M), and EV of EUR 262M (or $281M).
See Laboratorio Reig Jofre trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $281M | $236M | XXX | XXX | XXX | XXX | $0.20 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Laboratorio Reig Jofre has market cap of $236M and EV of $281M.
Laboratorio Reig Jofre's trades at 0.8x LTM EV/Revenue multiple, and 6.6x LTM EBITDA.
Analysts estimate Laboratorio Reig Jofre's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Laboratorio Reig Jofre and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $281M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 7.2x | XXX | XXX | XXX |
| P/E | 21.1x | XXX | XXX | XXX |
| P/E/Growth | 0.9x | XXX | XXX | XXX |
| EV/FCF | 24.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpLaboratorio Reig Jofre's NTM/LTM revenue growth is 7%
Laboratorio Reig Jofre's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Laboratorio Reig Jofre's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Laboratorio Reig Jofre's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Laboratorio Reig Jofre and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 18% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 53% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Laboratorio Reig Jofre acquired XXX companies to date.
Last acquisition by Laboratorio Reig Jofre was XXXXXXXX, XXXXX XXXXX XXXXXX . Laboratorio Reig Jofre acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Laboratorio Reig Jofre founded? | Laboratorio Reig Jofre was founded in 1993. |
| Where is Laboratorio Reig Jofre headquartered? | Laboratorio Reig Jofre is headquartered in Spain. |
| How many employees does Laboratorio Reig Jofre have? | As of today, Laboratorio Reig Jofre has 794 employees. |
| Is Laboratorio Reig Jofre publicy listed? | Yes, Laboratorio Reig Jofre is a public company listed on MAD. |
| What is the stock symbol of Laboratorio Reig Jofre? | Laboratorio Reig Jofre trades under RJF ticker. |
| When did Laboratorio Reig Jofre go public? | Laboratorio Reig Jofre went public in 2006. |
| Who are competitors of Laboratorio Reig Jofre? | Similar companies to Laboratorio Reig Jofre include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Laboratorio Reig Jofre? | Laboratorio Reig Jofre's current market cap is $236M |
| What is the current revenue of Laboratorio Reig Jofre? | Laboratorio Reig Jofre's last 12-month revenue is $369M. |
| What is the current EBITDA of Laboratorio Reig Jofre? | Laboratorio Reig Jofre's last 12-month EBITDA is $42.4M. |
| What is the current EV/Revenue multiple of Laboratorio Reig Jofre? | Current revenue multiple of Laboratorio Reig Jofre is 0.8x. |
| What is the current EV/EBITDA multiple of Laboratorio Reig Jofre? | Current EBITDA multiple of Laboratorio Reig Jofre is 6.6x. |
| What is the current revenue growth of Laboratorio Reig Jofre? | Laboratorio Reig Jofre revenue growth between 2023 and 2024 was 7%. |
| Is Laboratorio Reig Jofre profitable? | Yes, Laboratorio Reig Jofre is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
